Skip to Main Content

Author Details

Jianjiong Gao
Memorial Sloan Kettering Cancer Center
2009
75
40
PMIDPaper TitleJournal TitlePublished Year
37849038Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.Cancer Discov2024
37849038Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.Cancer Discov2024
34663944Harnessing multimodal data integration to advance precision oncology.Nat Rev Cancer2022
35764743Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.Nat Cancer2022
36517593Ovarian cancer mutational processes drive site-specific immune evasion.Nature2022
35040676Semisupervised Training of a Brain MRI Tumor Detection Model Using Mined Annotations.Radiology2022
34663944Harnessing multimodal data integration to advance precision oncology.Nat Rev Cancer2022
35148171Genome Nexus: A Comprehensive Resource for the Annotation and Interpretation of Genomic Variants in Cancer.JCO Clin Cancer Inform2022
35764743Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.Nat Cancer2022
36517593Ovarian cancer mutational processes drive site-specific immune evasion.Nature2022
35040676Semisupervised Training of a Brain MRI Tumor Detection Model Using Mined Annotations.Radiology2022
35148171Genome Nexus: A Comprehensive Resource for the Annotation and Interpretation of Genomic Variants in Cancer.JCO Clin Cancer Inform2022
33270827Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.Blood2021
33625877OncoTree: A Cancer Classification System for Precision Oncology.JCO Clin Cancer Inform2021
34260720Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.J Am Med Inform Assoc2021
33270827Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.Blood2021
34741162The context-specific role of germline pathogenicity in tumorigenesis.Nat Genet2021
33625877OncoTree: A Cancer Classification System for Precision Oncology.JCO Clin Cancer Inform2021
34741162The context-specific role of germline pathogenicity in tumorigenesis.Nat Genet2021
34260720Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.J Am Med Inform Assoc2021
32426342Detecting Cancer Survival Related Gene Markers Based on Rectified Factor Network.Front Bioeng Biotechnol2020
32426342Detecting Cancer Survival Related Gene Markers Based on Rectified Factor Network.Front Bioeng Biotechnol2020
32246132A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.Nat Genet2020
32332851Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.Nat Commun2020
31658877How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study.J Biomol Struct Dyn2020
32641410Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in Cancer.Cancer Res2020
33119407Multiomic Integration of Public Oncology Databases in Bioconductor.JCO Clin Cancer Inform2020
31658877How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study.J Biomol Struct Dyn2020
33119407Multiomic Integration of Public Oncology Databases in Bioconductor.JCO Clin Cancer Inform2020
32641410Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in Cancer.Cancer Res2020
32246132A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.Nat Genet2020
32332851Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.Nat Commun2020
31152158Publisher Correction: The long tail of oncogenic drivers in prostate cancer.Nat Genet2019
32914011Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets.JCO Precis Oncol2019
31152158Publisher Correction: The long tail of oncogenic drivers in prostate cancer.Nat Genet2019
31308250Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.Mol Cell Proteomics2019
32914011Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets.JCO Precis Oncol2019
31308250Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.Mol Cell Proteomics2019
29316426Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.Cancer Cell2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29625053Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29625050Oncogenic Signaling Pathways in The Cancer Genome Atlas.Cell2018
29533785Systematic Functional Annotation of Somatic Mutations in Cancer.Cancer Cell2018
29664468Unifying cancer and normal RNA sequencing data from different sources.Sci Data2018
29385402G2S: a web-service for annotating genomic variants on 3D protein structures.Bioinformatics2018
29610475The long tail of oncogenic drivers in prostate cancer.Nat Genet2018
29122777Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.Cancer Discov2018
29247016Accelerating Discovery of Functional Mutant Alleles in Cancer.Cancer Discov2018
29316426Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.Cancer Cell2018
29804638A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer.Gynecol Oncol2018
  • 1 - 50 of 150

Recommended Authors

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 7
Washington University
Career Start Year 2016
Number of shared co-authors 12
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Career Start Year 2014
Number of shared co-authors 19
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 30
Ontario Institute for Cancer Research
Career Start Year 2011
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 15
Washington University
Career Start Year 2009
Number of shared co-authors 61
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 40
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2008
Number of shared co-authors 9
Norwegian University of Science and Technology
Career Start Year 2008
Number of shared co-authors 20
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 1
Ontario Institute for Cancer Research
Career Start Year 2007
Number of shared co-authors 44
Broad Institute of Harvard and MIT
Career Start Year 2007
Number of shared co-authors 19
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 4
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 21
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 7
University of Zurich
Career Start Year 2005
Number of shared co-authors 12
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 10
University of Augsburg
Career Start Year 2004
Number of shared co-authors 14
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 3
Cystic Fibrosis Foundation
Career Start Year 2003
Number of shared co-authors 34
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University
Career Start Year 2003
Number of shared co-authors 2
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 15
University of California at Santa Cruz
Career Start Year 2001
Number of shared co-authors 47
University of Toronto
Career Start Year 2000
Number of shared co-authors 40
Ontario Institute for Cancer Research
Career Start Year 1999
Number of shared co-authors 8
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year 1998
Number of shared co-authors 28
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 8
The University of Queensland Diamantina Institute, The University of Queensland
Career Start Year 1997
Number of shared co-authors 13
University of California San Diego
Career Start Year 1992
Number of shared co-authors 41

Collaborators

Memorial Sloan Kettering Cancer Center
Co-authored papers 41
Memorial Sloan Kettering Cancer Center
Co-authored papers 17
Memorial Sloan Kettering Cancer Center
Co-authored papers 16
Co-authored papers 15
Memorial Sloan Kettering Cancer Center
Co-authored papers 14
University of Missouri
Co-authored papers 13
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Broad Institute of MIT and Harvard
Co-authored papers 10
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Dana-Farber Cancer Institute
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Boston University
Co-authored papers 7
University of Cuenca
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Co-authored papers 5
Oncology R&D
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Broad Institute of Harvard and MIT
Co-authored papers 4
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
The Institute of Cancer Research
Co-authored papers 4